Stock analysts at Alliance Global Partners initiated coverage on shares of Sensus Healthcare (NASDAQ:SRTS – Get Free Report) in a research report issued on Friday. The firm set a “buy” rating and a $7.50 price target on the stock. Alliance Global Partners’ price target points to a potential upside of 75.23% from the stock’s previous […]